Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement
Kosmaczewska, Agata, Swierkot, Jerzy, Ciszak, Lidia, Szteblich, Aleksandra, Chrobak, Agnieszka, Karabon, Lidia, Partyka, Anna, Szechinski, Jacek, Wiland, Piotr, Frydecka, IrenaVolume:
34
Language:
english
Journal:
Rheumatology International
DOI:
10.1007/s00296-013-2895-9
Date:
February, 2014
File:
PDF, 581 KB
english, 2014